The substantial beat on both earnings per share and sales estimates, coupled with a significant year-over-year growth in earnings and sales, is likely to positively impact investor sentiment and the stock price of Neurocrine Biosciences in the short term. The company's performance indicates strong operational efficiency and market demand for its products, which could lead to increased investor confidence and potential stock price appreciation.